Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733615 · ClinicalTrials.gov registry record
Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01733615 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 3 participants.
The verdict
NCT01733615 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to find out more about some of the unusual chemicals (called oligosaccharides) that can occur naturally as a result of processes in the body. Researchers want to look at how these chemicals change with time and how they change between different patients with MPSIVA. These unusual chemicals were recently discovered in the urine from patients with MPSIVA. The investigators would like to study these chemicals before a specific enzyme replacement therapy is used. If the investigators understand how these chemicals change, the investigators may be able to use them to monitor this condition in the near future as well as help doctors know whether certain therapies work well in their patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01733615
The ClinicalTrials.gov registry entry for NCT01733615 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01733615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01733615 about?
NCT01733615 is a clinical study titled "Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA". The purpose of this study is to find out more about some of the unusual chemicals (called oligosaccharides) that can occur naturally as a result of processes in the body. Researchers want to look at how these chemicals change with time and how they change between different patients with MPSIVA. Thes...
What is the current status of trial NCT01733615?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2012-06. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01733615?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.